- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Research Data /
- Data from: The prevalence of MS in the United States:...
Open Collections
UBC Research Data
Data from: The prevalence of MS in the United States: a population-based estimate using health claims data Wallin, Mitchell T.; Culpepper, William J.; Campbell, Jonathan D.; Nelson, Lorene M.; Langer-Gould, Annette; Marrie, Ruth Ann; Cutter, Gary R.; Kaye, Wendy E.; Wagner, Laurie; Tremlett, Helen; Buka, Stephen L.; Dilokthornsakul, Piyameth; Topol, Barbara; Chen, Lie H.; LaRocca, Nicholas G.
Description
Abstract
Objective: To generate a national multiple sclerosis (MS) prevalence estimate for the United States by
applying a validated algorithm to multiple administrative health claims (AHC) datasets.
Methods: A validated algorithm was applied to private, military, and public AHC datasets to identify adult
cases of MS between 2008 and 2010. In each dataset, we determined the 3-year cumulative
prevalence overall and stratified by age, sex, and census region. We applied insurance-specific
and stratum-specific estimates to the 2010 US Census data and pooled the findings to calculate
the 2010 prevalence of MS in the United States cumulated over 3 years. We also estimated the
2010 prevalence cumulated over 10 years using 2 models and extrapolated our estimate to 2017.
Results: The estimated 2010 prevalence of MS in the US adult population cumulated over 10 years was
309.2 per 100,000 (95% confidence interval [CI] 308.1–310.1), representing 727,344 cases.
During the same time period, the MS prevalence was 450.1 per 100,000 (95% CI 448.1–451.6)
for women and 159.7 (95% CI 158.7–160.6) for men (female:male ratio 2.8). The estimated
2010 prevalence of MS was highest in the 55- to 64-year age group. A US north-south
decreasing prevalence gradient was identified. The estimated MS prevalence is also presented
for 2017.
Conclusion: The estimated US national MS prevalence for 2010 is the highest reported to date and provides
evidence that the north-south gradient persists. Our rigorous algorithm-based approach to
estimating prevalence is efficient and has the potential to be used for other chronic neurologic
conditions.
Usage notes
Prev of MS in the US-E-Appendix-Feb-19-2018
Item Metadata
| Title |
Data from: The prevalence of MS in the United States: a population-based estimate using health claims data
|
| Creator | |
| Date Issued |
2021-05-19
|
| Description |
Abstract
Objective: To generate a national multiple sclerosis (MS) prevalence estimate for the United States by applying a validated algorithm to multiple administrative health claims (AHC) datasets. Methods: A validated algorithm was applied to private, military, and public AHC datasets to identify adult cases of MS between 2008 and 2010. In each dataset, we determined the 3-year cumulative prevalence overall and stratified by age, sex, and census region. We applied insurance-specific and stratum-specific estimates to the 2010 US Census data and pooled the findings to calculate the 2010 prevalence of MS in the United States cumulated over 3 years. We also estimated the 2010 prevalence cumulated over 10 years using 2 models and extrapolated our estimate to 2017. Results: The estimated 2010 prevalence of MS in the US adult population cumulated over 10 years was 309.2 per 100,000 (95% confidence interval [CI] 308.1–310.1), representing 727,344 cases. During the same time period, the MS prevalence was 450.1 per 100,000 (95% CI 448.1–451.6) for women and 159.7 (95% CI 158.7–160.6) for men (female:male ratio 2.8). The estimated 2010 prevalence of MS was highest in the 55- to 64-year age group. A US north-south decreasing prevalence gradient was identified. The estimated MS prevalence is also presented for 2017. Conclusion: The estimated US national MS prevalence for 2010 is the highest reported to date and provides evidence that the north-south gradient persists. Our rigorous algorithm-based approach to estimating prevalence is efficient and has the potential to be used for other chronic neurologic conditions.; Usage notes Prev of MS in the US-E-Appendix-Feb-19-2018 |
| Subject | |
| Type | |
| Notes |
Dryad version number: 1 Version status: submitted Dryad curation status: Published Sharing link: https://datadryad.org/stash/share/LjXyJvj619bVE1cpe_NxmWKDnsRvJFeeTJsPgrl2Px8</p> Storage size: 49825 Visibility: public |
| Date Available |
2020-06-24
|
| Provider |
University of British Columbia Library
|
| License |
CC0 1.0
|
| DOI |
10.14288/1.0397682
|
| URI | |
| Publisher DOI | |
| Rights URI | |
| Aggregated Source Repository |
Dataverse
|
Item Media
Item Citations and Data
License
CC0 1.0